{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T08:02:21Z","timestamp":1740124941993,"version":"3.37.3"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T00:00:00Z","timestamp":1728345600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T00:00:00Z","timestamp":1728345600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1038\/s41433-024-03381-x","type":"journal-article","created":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T03:36:33Z","timestamp":1728358593000},"page":"94-101","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ocular effects of synthetic cannabinoids: a case-control study"],"prefix":"10.1038","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7488-6295","authenticated-orcid":false,"given":"Merve Sena","family":"Kundurac\u0131","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5846-8536","authenticated-orcid":false,"given":"Furkan","family":"K\u0131r\u0131k","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9028-2421","authenticated-orcid":false,"given":"Ismail Umut","family":"Onur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0447-4636","authenticated-orcid":false,"given":"Ozge Sahmelikoglu","family":"Onur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cagatay","family":"Karsidag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fadime Ulviye","family":"Yigit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murat","family":"Erkiran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,10,8]]},"reference":[{"key":"3381_CR1","doi-asserted-by":"crossref","unstructured":"Russo EB, Grotenhermen F (eds). The handbook of cannabis therapeutics: from bench to bedside. Binghamton: The Haworth Press; 2014.","DOI":"10.4324\/9780203820803"},{"key":"3381_CR2","doi-asserted-by":"publisher","first-page":"403","DOI":"10.2174\/187152709789824660","volume":"8","author":"J Guindon","year":"2009","unstructured":"Guindon J, Hohmann AG. The endocannabinoid system and pain. CNS Neurol Disord Drug Targets. 2009;8:403\u201321.","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"3381_CR3","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.psychres.2018.01.046","volume":"262","author":"HY Cengel","year":"2018","unstructured":"Cengel HY, Bozkurt M, Evren C, Umut G, Keskinkilic C, Agachanli R. Evaluation of cognitive functions in individuals with synthetic cannabinoid use disorder and comparison to individuals with cannabis use disorder. Psychiatry Res. 2018;262:46\u201354.","journal-title":"Psychiatry Res"},{"key":"3381_CR4","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.toxlet.2010.06.002","volume":"197","author":"I Vardakou","year":"2010","unstructured":"Vardakou I, Pistos C, Spiliopoulou C. Spice drugs as a new trend: mode of action, identification and legislation. Toxicol Lett. 2010;197:157\u201362.","journal-title":"Toxicol Lett"},{"key":"3381_CR5","first-page":"41","volume":"1","author":"M \u00c7oban","year":"2014","unstructured":"\u00c7oban M. The rise of synthetic marijuana in Turkey: the Bonzai phenomenon of the 2010s. Addicta Turkish J Addict. 2014;1:41\u201362.","journal-title":"Addicta Turkish J Addict"},{"key":"3381_CR6","unstructured":"Sedefov R, Gallegos A, King L, Lopez D, Auwarter V, Hughes B, et al. Understanding the \u2018Spice\u2019 phenomenon. Thematic papers. Lisbon: European Monitoring Centre for Drugs and Drug Addiction; 2019."},{"key":"3381_CR7","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/S0161-6420(80)35258-5","volume":"87","author":"JC Merritt","year":"1980","unstructured":"Merritt JC, Crawford WJ, Alexander PC, Anduze AL, Gelbart SS. Effect of marihuana on intraocular and blood pressure in glaucoma. Ophthalmology. 1980;87:222\u20138.","journal-title":"Ophthalmology"},{"key":"3381_CR8","first-page":"921","volume":"7","author":"WD Purnell","year":"1975","unstructured":"Purnell WD, Gregg JM. Delta(9)-tetrahydrocannabinol, euphoria and intraocular pressure in man. Ann Ophthalmol. 1975;7:921\u20133.","journal-title":"Ann Ophthalmol"},{"key":"3381_CR9","first-page":"947","volume":"12","author":"J Merritt","year":"1980","unstructured":"Merritt J, McKinnon S, Armstrong J, Hatem G, Reid L. Oral delta-9-tetrahydrocannabinol in heterogeneous glaucomas. Ann Ophthalmol. 1980;12:947\u201350.","journal-title":"Ann Ophthalmol"},{"key":"3381_CR10","doi-asserted-by":"publisher","first-page":"472S","DOI":"10.1002\/j.1552-4604.1981.tb02627.x","volume":"21","author":"M Elsohly","year":"1981","unstructured":"Elsohly M, Harland E, Murphy J, Wirth P, Waller C. Cannabinoids in glaucoma: a primary screening procedure. J Clin Pharm. 1981;21:472S\u20138S.","journal-title":"J Clin Pharm"},{"key":"3381_CR11","doi-asserted-by":"publisher","first-page":"841","DOI":"10.3109\/02713688409000797","volume":"3","author":"MA Elsohly","year":"1984","unstructured":"Elsohly MA, Harland EC, Benigni DA, Waller CW. Cannabinoids in glaucoma II: the effect of different cannabinoids on intraocular pressure of the rabbit. Curr Eye Res. 1984;3:841\u201350.","journal-title":"Curr Eye Res"},{"key":"3381_CR12","first-page":"53","volume":"26","author":"SM Gurney","year":"2014","unstructured":"Gurney SM, Scott KS, Kacinko SL, Presley BC, Logan BK. Pharmacology, toxicology, and adverse effects of synthetic cannabinoid drugs. Forensic Sci Rev. 2014;26:53\u201378.","journal-title":"Forensic Sci Rev"},{"key":"3381_CR13","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1111\/ceo.13467","volume":"47","author":"B Liu","year":"2019","unstructured":"Liu B, Zhang X, Mi L, Peng Y, Wen F. Choroidal structure in subtypes of polypoidal choroidal vasculopathy determined by binarization of optical coherence tomographic images. Clin Exp Ophthalmol. 2019;47:631\u20137.","journal-title":"Clin Exp Ophthalmol"},{"key":"3381_CR14","doi-asserted-by":"publisher","first-page":"e0146344","DOI":"10.1371\/journal.pone.0146344","volume":"11","author":"R Agrawal","year":"2016","unstructured":"Agrawal R, Salman M, Tan KA, Karampelas M, Sim DA, Keane PA, et al. Choroidal vascularity index (CVI)-a novel optical coherence tomography parameter for monitoring patients with panuveitis? PLoS One. 2016;11:e0146344.","journal-title":"PLoS One"},{"key":"3381_CR15","doi-asserted-by":"publisher","first-page":"327","DOI":"10.2165\/00003088-200342040-00003","volume":"42","author":"F Grotenhermen","year":"2003","unstructured":"Grotenhermen F. Pharmacokinetics and pharmacodynamics of cannabinoids. Clin Pharmacokinet. 2003;42:327\u201360.","journal-title":"Clin Pharmacokinet"},{"key":"3381_CR16","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1021\/acs.chemrev.5b00411","volume":"116","author":"M Aghazadeh Tabrizi","year":"2016","unstructured":"Aghazadeh Tabrizi M, Baraldi PG, Borea PA, Varani K. Medicinal chemistry, pharmacology, and potential therapeutic benefits of cannabinoid CB2 receptor agonists. Chem Rev. 2016;116:519\u201360.","journal-title":"Chem Rev"},{"key":"3381_CR17","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1111\/bcp.13710","volume":"84","author":"CJ Lucas","year":"2018","unstructured":"Lucas CJ, Galettis P, Schneider J. The pharmacokinetics and the pharmacodynamics of cannabinoids. Br J Clin Pharm. 2018;84:2477\u201382.","journal-title":"Br J Clin Pharm"},{"key":"3381_CR18","doi-asserted-by":"publisher","first-page":"2916732","DOI":"10.1155\/2016\/2916732","volume":"2016","author":"T Schwitzer","year":"2016","unstructured":"Schwitzer T, Schwan R, Angioi-Duprez K, Giersch A, Laprevote V. The endocannabinoid system in the retina: from physiology to practical and therapeutic applications. Neural Plast. 2016;2016:2916732.","journal-title":"Neural Plast"},{"key":"3381_CR19","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/S0169-328X(98)00105-3","volume":"58","author":"A Porcella","year":"1998","unstructured":"Porcella A, Casellas P, Gessa GL, Pani L. Cannabinoid receptor CB1 mRNA is highly expressed in the rat ciliary body: implications for the antiglaucoma properties of marihuana. Brain Res Mol Brain Res. 1998;58:240\u20135.","journal-title":"Brain Res Mol Brain Res"},{"key":"3381_CR20","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1046\/j.1460-9568.2000.01027.x","volume":"12","author":"A Porcella","year":"2000","unstructured":"Porcella A, Maxia C, Gessa GL, Pani L. The human eye expresses high levels of CB1 cannabinoid receptor mRNA and protein. Eur J Neurosci. 2000;12:1123\u20137.","journal-title":"Eur J Neurosci"},{"key":"3381_CR21","first-page":"2442","volume":"40","author":"AJ Straiker","year":"1999","unstructured":"Straiker AJ, Maguire G, Mackie K, Lindsey J. Localization of cannabinoid CB1 receptors in the human anterior eye and retina. Invest Ophthalmol Vis Sci. 1999;40:2442\u20138.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3381_CR22","first-page":"1243","volume":"15","author":"Y Wei","year":"2009","unstructured":"Wei Y, Wang X, Wang L. Presence and regulation of cannabinoid receptors in human retinal pigment epithelial cells. Mol Vis. 2009;15:1243\u201351.","journal-title":"Mol Vis"},{"key":"3381_CR23","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.exer.2019.03.011","volume":"182","author":"N Murataeva","year":"2019","unstructured":"Murataeva N, Miller S, Dhopeshwarkar A, Leishman E, Daily L, Taylor X, et al. Cannabinoid CB2R receptors are upregulated with corneal injury and regulate the course of corneal wound healing. Exp Eye Res. 2019;182:74\u201384.","journal-title":"Exp Eye Res"},{"key":"3381_CR24","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/S0079-6123(08)01131-X","volume":"173","author":"C Nucci","year":"2008","unstructured":"Nucci C, Bari M, Span\u00f2 A, Corasaniti M, Bagetta G, Maccarrone M, et al. Potential roles of (endo)cannabinoids in the treatment of glaucoma: from intraocular pressure control to neuroprotection. Prog Brain Res. 2008;173:451\u201364.","journal-title":"Prog Brain Res"},{"key":"3381_CR25","doi-asserted-by":"publisher","first-page":"9364091","DOI":"10.1155\/2016\/9364091","volume":"2016","author":"EA Cairns","year":"2016","unstructured":"Cairns EA, Baldridge WH, Kelly ME. The endocannabinoid system as a therapeutic target in glaucoma. Neural Plast. 2016;2016:9364091.","journal-title":"Neural Plast"},{"key":"3381_CR26","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.survophthal.2020.07.002","volume":"66","author":"MTM Wang","year":"2021","unstructured":"Wang MTM, Danesh-Meyer HV. Cannabinoids and the eye. Surv Ophthalmol. 2021;66:327\u201345.","journal-title":"Surv Ophthalmol"},{"key":"3381_CR27","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1001\/jama.1971.03190100074024","volume":"217","author":"RS Hepler","year":"1971","unstructured":"Hepler RS, Frank IR. Marihuana smoking and intraocular pressure. JAMA. 1971;217:1392.","journal-title":"JAMA"},{"key":"3381_CR28","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/S0161-6420(79)35539-7","volume":"86","author":"FW Newell","year":"1979","unstructured":"Newell FW, Stark P, Jay WM, Schanzlin DJ. Nabilone: a pressure-reducing synthetic benzopyran in open-angle glaucoma. Ophthalmology. 1979;86:156\u201360.","journal-title":"Ophthalmology"},{"key":"3381_CR29","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/S0161-6420(81)35052-0","volume":"88","author":"JS Tiedeman","year":"1981","unstructured":"Tiedeman JS, Shields MB, Weber PA, Crow JW, Cocchetto DM, Harris WA, et al. Effect of synthetic cannabinoids on elevated intraocular pressure. Ophthalmology. 1981;88:270\u20137.","journal-title":"Ophthalmology"},{"key":"3381_CR30","unstructured":"Perez-Reyes M, Wagner D, Wall M, Davis K. Intravenous administration of cannabinoids and intraocular pressure. In: Braude MC, Szara S (eds). Pharmacology of Marihuana. New York: Raven Press; 1976. p. 829\u201332."},{"key":"3381_CR31","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1097\/00007611-197708000-00016","volume":"70","author":"P Cooler","year":"1977","unstructured":"Cooler P, Gregg JM. Effect of delta-9-tetrahydrocannabinol on intraocular pressure in humans. South Med J. 1977;70:951\u20134.","journal-title":"South Med J"},{"key":"3381_CR32","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1046\/j.0953-816X.2000.01401.x","volume":"13","author":"A Porcella","year":"2001","unstructured":"Porcella A, Maxia C, Gessa GL, Pani L. The synthetic cannabinoid WIN55212-2 decreases the intraocular pressure in human glaucoma resistant to conventional therapies. Eur J Neurosci. 2001;13:409\u201312.","journal-title":"Eur J Neurosci"},{"key":"3381_CR33","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s40135-019-00214-z","volume":"7","author":"J Katz","year":"2019","unstructured":"Katz J, Costarides AP. Facts vs fiction: the role of cannabinoids in the treatment of glaucoma. Curr Ophthalmol Rep. 2019;7:177\u201381.","journal-title":"Curr Ophthalmol Rep"},{"key":"3381_CR34","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1002\/jps.22791","volume":"101","author":"T Hingorani","year":"2012","unstructured":"Hingorani T, Gul W, Elsohly M, Repka MA, Majumdar S. Effect of ion pairing on in vitro transcorneal permeability of a \u0394(9) -tetrahydrocannabinol prodrug: potential in glaucoma therapy. J Pharm Sci. 2012;101:616\u201326.","journal-title":"J Pharm Sci"},{"key":"3381_CR35","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.preteyeres.2009.12.002","volume":"29","author":"DL Nickla","year":"2010","unstructured":"Nickla DL, Wallman J. The multifunctional choroid. Prog Retin Eye Res. 2010;29:144\u20131468.","journal-title":"Prog Retin Eye Res"},{"key":"3381_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2020.100829","volume":"77","author":"R Agrawal","year":"2020","unstructured":"Agrawal R, Ding J, Sen P, Rousselot A, Chan A, Nivison-Smith L, et al. Exploring choroidal angioarchitecture in health and disease using choroidal vascularity index. Prog Retin Eye Res. 2020;77:100829.","journal-title":"Prog Retin Eye Res"},{"key":"3381_CR37","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1136\/bjophthalmol-2021-318782","volume":"106","author":"BK Betzler","year":"2022","unstructured":"Betzler BK, Ding J, Wei X, Lee JM, Grewal DS, Fekrat S, et al. Choroidal vascularity index: a step towards software as a medical device. Br J Ophthalmol. 2022;106:149\u201355.","journal-title":"Br J Ophthalmol"},{"key":"3381_CR38","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.survophthal.2018.11.002","volume":"64","author":"SR Singh","year":"2019","unstructured":"Singh SR, Vupparaboina KK, Goud A, Dansingani KK, Chhablani J. Choroidal imaging biomarkers. Surv Ophthalmol. 2019;64:312\u201333.","journal-title":"Surv Ophthalmol"},{"key":"3381_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-48613-3","volume":"9","author":"J Baek","year":"2019","unstructured":"Baek J, Lee A, Chu M, Kang NY. Analysis of choroidal vascularity in children with unilateral hyperopic amblyopia. Sci Rep. 2019;9:12143.","journal-title":"Sci Rep"},{"key":"3381_CR40","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1097\/IAE.0000000000001312","volume":"37","author":"X Wei","year":"2017","unstructured":"Wei X, Ting DSW, Ng WY, Khandelwal N, Agrawal R, Cheung CMG. CHOROIDAL VASCULARITY INDEX: a novel optical coherence tomography based parameter in patients with exudative age-related macular degeneration. Retina. 2017;37:1120\u20135.","journal-title":"Retina"},{"key":"3381_CR41","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1080\/09273948.2017.1370650","volume":"26","author":"A Agarwal","year":"2018","unstructured":"Agarwal A, Agrawal R, Khandelwal N, Invernizzi A, Aggarwal K, Sharma A, et al. Choroidal structural changes in tubercular multifocal serpiginoid choroiditis. Ocul Immunol Inflamm. 2018;26:838\u201344.","journal-title":"Ocul Immunol Inflamm"},{"key":"3381_CR42","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3928\/23258160-20180221-07","volume":"49","author":"R Tan","year":"2018","unstructured":"Tan R, Agrawal R, Taduru S, Gupta A, Vupparaboina K, Chhablani J. Choroidal vascularity index in retinitis pigmentosa: an OCT study. Ophthalmic Surg Lasers Imaging Retin. 2018;49:191\u20137.","journal-title":"Ophthalmic Surg Lasers Imaging Retin"},{"key":"3381_CR43","doi-asserted-by":"publisher","first-page":"622","DOI":"10.3389\/fphys.2018.00622","volume":"9","author":"JS Richter","year":"2018","unstructured":"Richter JS, Quenardelle V, Rouyer O, Raul JS, Beaujeux R, G\u00e9ny B, et al. A systematic review of the complex effects of cannabinoids on cerebral and peripheral circulation in animal models. Front Physiol. 2018;9:622.","journal-title":"Front Physiol"},{"key":"3381_CR44","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.yebeh.2017.01.031","volume":"70","author":"V Wolff","year":"2017","unstructured":"Wolff V, Jouanjus E. Strokes are possible complications of cannabinoids use. Epilepsy Behav. 2017;70:355\u201363.","journal-title":"Epilepsy Behav"},{"key":"3381_CR45","first-page":"146","volume":"116","author":"VN Subramaniam","year":"2019","unstructured":"Subramaniam VN, Menezes AR, DeSchutter A, Lavie CJ. The cardiovascular effects of marijuana: are the potential adverse effects worth the high? Mo Med. 2019;116:146\u201353.","journal-title":"Mo Med"},{"key":"3381_CR46","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.preteyeres.2017.12.001","volume":"64","author":"A Reiner","year":"2018","unstructured":"Reiner A, Fitzgerald MEC, Del Mar N, Li C. Neural control of choroidal blood flow. Prog Retin Eye Res. 2018;64:96\u2013130.","journal-title":"Prog Retin Eye Res"},{"key":"3381_CR47","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1038\/eye.2014.100","volume":"28","author":"EJ Sigler","year":"2014","unstructured":"Sigler EJ, Randolph JC, Calzada JI, Charles S. Smoking and choroidal thickness in patients over 65 with early-atrophic age-related macular degeneration and normals. Eye (Lond). 2014;28:838\u201346.","journal-title":"Eye (Lond)"},{"key":"3381_CR48","doi-asserted-by":"publisher","first-page":"20","DOI":"10.4274\/tjo.galenos.2018.80588","volume":"49","author":"K Teberik","year":"2019","unstructured":"Teberik K. The effect of smoking on macular, choroidal, and retina nerve fiber layer thickness. Turk J Ophthalmol. 2019;49:20\u20134.","journal-title":"Turk J Ophthalmol"},{"key":"3381_CR49","doi-asserted-by":"publisher","first-page":"504","DOI":"10.3109\/02713683.2013.850099","volume":"39","author":"F Ula\u015f","year":"2014","unstructured":"Ula\u015f F, \u00c7elik F, Do\u011fan \u00dc, \u00c7elebi S. Effect of smoking on choroidal thickness in healthy smokers. Curr Eye Res. 2014;39:504\u201311.","journal-title":"Curr Eye Res"},{"key":"3381_CR50","doi-asserted-by":"publisher","first-page":"8079127","DOI":"10.1155\/2019\/8079127","volume":"2019","author":"TK Yang","year":"2019","unstructured":"Yang TK, Huang XG, Yao JY. Effects of cigarette smoking on retinal and choroidal thickness: a systematic review and meta-analysis. J Ophthalmol. 2019;2019:8079127.","journal-title":"J Ophthalmol"},{"key":"3381_CR51","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1167\/iovs.18-25764","volume":"60","author":"X Wei","year":"2019","unstructured":"Wei X, Kumar S, Ding J, Khandelwal N, Agarwal M, Agrawal R. Choroidal structural changes in smokers measured using choroidal vascularity index. Invest Ophthalmol Vis Sci. 2019;60:1316\u201320.","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-024-03381-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-024-03381-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-024-03381-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T20:10:22Z","timestamp":1736885422000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-024-03381-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,8]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["3381"],"URL":"https:\/\/doi.org\/10.1038\/s41433-024-03381-x","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"type":"print","value":"0950-222X"},{"type":"electronic","value":"1476-5454"}],"subject":[],"published":{"date-parts":[[2024,10,8]]},"assertion":[{"value":"8 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}